BIOMEDITECH ApS: Financial statements 2021
CVR: 34707847
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 76,139 compared with DKK 16,722 the year before. Equity in the 2021 report amounted to DKK 127,026. The solvency ratio was 99.4%.
- Profit/Loss
- DKK 76,139
- Equity
- DKK 127,026
- Total Assets
- DKK 127,781
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | 76K | 127K | - |
| 2020 | 27K | 27K | 17K | 51K | - |
| 2019 | - | - | -13K | 34K | - |
| 2018 | - | - | -18K | 47K | - |
| 2017 | - | - | -28K | 65K | - |
Official annual report
Find more companies like BIOMEDITECH ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
BIOMEDITECH ApS has published its annual report for 2020. Revenue came to DKK 27,491, and the net result was DKK 16,722.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.